AMP-activated protein kinase (AMPK) Activators encompass a diverse range of chemical compounds that promote the functional activity of AMPK, a pivotal enzyme in regulating cellular energy homeostasis. A-769662 directly engages AMPK by allosterically binding to its β1 subunit, enhancing its phosphorylation and activity, while 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is metabolized into ZMP, an AMP analog that activates AMPK by simulating conditions of energy scarcity. Metformin, a widely known antidiabetic drug, indirectly stimulates AMPK activity by inhibiting mitochondrial complex I, leading to an increased AMP/ATP ratio which is a key activator of AMPK. Resveratrol, a polyphenolic compound, indirectly augments AMPK activity through SIRT1-mediated deacetylation of LKB1, an upstream kinase of AMPK. Salicylate and berberine enhance AMPK activity by altering the phosphorylation status of upstream kinases and stabilizing the AMP/ATP ratio, respectively, resulting in increased AMPK phosphorylation. Dinitrophenol and alpha-lipoic acid modulate mitochondrial function, leading to a higher AMP/ATP ratio and subsequent AMPK activation.
Further exploration of AMPK activators reveals quercetin and genistein as flavonoids that indirectly trigger AMPK activation through the modulation of AMP levels or by influencing kinases that phosphorylate AMPK. Capsaicin activates AMPK by promoting calcium influx and subsequently increasing the activity of CaMKKβ, an upstream kinase of AMPK. Lastly, curcumin enhances AMPK activity through pathways reliant on LKB1 and the potential modulation of AMP levels. Collectively, these AMPK Activators function through a myriad of biochemical mechanisms, ultimately converging on the activation of AMPK to sustain energy balance within the cell. These activators operate by mimicking energy depletion, modulating enzyme phosphorylation, or altering mitochondrial function, thereby ensuring that AMPK
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
A small protein protease inhibitor that inhibits several serine proteases; indirectly increases KLKB1 activity by protecting it from proteolytic degradation by plasma kallikrein and other serine proteases. | ||||||
Trypsin Inhibitor, soybean | 9035-81-8 | sc-29129 sc-29129A sc-29129B sc-29129C sc-29129D sc-29129F sc-29129E | 50 mg 250 mg 1 g 5 g 10 g 25 g 100 g | $41.00 $135.00 $288.00 $1100.00 $1600.00 $2600.00 $10500.00 | 14 | |
A protease inhibitor that targets trypsin and related proteases; by inhibiting these proteases, the inhibitor can indirectly enhance KLKB1 activity by reducing its proteolytic inactivation. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
A synthetic protease inhibitor that mainly inhibits serine proteases; by inhibiting enzymes that degrade KLKB1, gabexate mesilate indirectly preserves the functional activity of KLKB1. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
A broad-spectrum serine protease inhibitor with anticoagulant properties; indirectly enhances KLKB1 activity by protecting it from proteolytic degradation. | ||||||
Tranexamic acid | 1197-18-8 | sc-204921 sc-204921A | 5 g 10 g | $29.00 $50.00 | 10 | |
An antifibrinolytic that inhibits plasminogen activation; by doing so, it indirectly enhances KLKB1 activity by reducing plasmin-mediated degradation of KLKB1. | ||||||
Argatroban | 74863-84-6 | sc-201310 sc-201310A | 10 mg 50 mg | $117.00 $469.00 | 13 | |
A direct thrombin inhibitor; enhances KLKB1 activity by inhibiting thrombin, which can lead to decreased proteolytic inactivation of KLKB1. | ||||||
Bivalirudin | 128270-60-0 | sc-278793 | 5 mg | $110.00 | ||
A synthetic peptide that inhibits thrombin; indirectly increases the activity of KLKB1 by inhibiting thrombin, which may otherwise cleave and inactivate KLKB1. | ||||||